MA46972A - Forme polymorphe de sépiaptérine - Google Patents

Forme polymorphe de sépiaptérine

Info

Publication number
MA46972A
MA46972A MA046972A MA46972A MA46972A MA 46972 A MA46972 A MA 46972A MA 046972 A MA046972 A MA 046972A MA 46972 A MA46972 A MA 46972A MA 46972 A MA46972 A MA 46972A
Authority
MA
Morocco
Prior art keywords
sepiapterin
polymorphic form
polymorphic
Prior art date
Application number
MA046972A
Other languages
English (en)
Inventor
Kaito Kishimoto
Taichi Komoda
Daniel E Levy
Takayoshi Matsumoto
Shunichi Murata
Yuichi Shiro
Hiroshi Yoshino
Original Assignee
Censa Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Censa Pharmaceuticals Inc filed Critical Censa Pharmaceuticals Inc
Publication of MA46972A publication Critical patent/MA46972A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
MA046972A 2016-11-29 2017-11-28 Forme polymorphe de sépiaptérine MA46972A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662427686P 2016-11-29 2016-11-29

Publications (1)

Publication Number Publication Date
MA46972A true MA46972A (fr) 2019-10-09

Family

ID=62241955

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046972A MA46972A (fr) 2016-11-29 2017-11-28 Forme polymorphe de sépiaptérine

Country Status (8)

Country Link
US (2) US11130760B2 (fr)
EP (1) EP3548487A4 (fr)
JP (1) JP7148532B2 (fr)
CN (1) CN110312721A (fr)
CA (1) CA3043499A1 (fr)
MA (1) MA46972A (fr)
MX (1) MX2019006207A (fr)
WO (1) WO2018102314A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5066756B2 (ja) 2010-04-22 2012-11-07 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
CN110248948B (zh) 2016-11-29 2023-07-28 Ptc医疗Mp公司 墨蝶呤及其盐的多晶型物
CA3073957A1 (fr) 2017-09-01 2019-03-07 Censa Pharmaceuticals Inc. Composition pharmaceutique comprenant de la sepiapterine et ses utilisations
CN112543758A (zh) * 2018-05-30 2021-03-23 Ptc医疗Mp公司 墨蝶呤的药学上可接受的盐
WO2019232130A1 (fr) 2018-05-30 2019-12-05 Censa Pharmaceuticals Inc. Procédés pour augmenter l'exposition au plasma de sépiaptérine
MX2022001535A (es) 2019-08-05 2022-03-04 Ptc Therapeutics Mp Inc Uso de sepiapterina y metabolitos de los mismos para tratar la exposicion a radiacion.
CA3150003A1 (fr) 2019-09-25 2021-04-01 Niel SMITH Procedes de traitement de l'hyperphenylalaninemie
AU2021209935A1 (en) 2020-01-24 2022-08-18 Ptc Therapeutics Mp, Inc. Methods for treating Parkinson's disease with sepiapterin
US20240115572A1 (en) 2021-02-09 2024-04-11 Ptc Therapeutics Mp, Inc. Methods for treating glioblastomas with sepiapterin
US20240122931A1 (en) 2021-02-09 2024-04-18 Ptc Therapeutics Mp, Inc. Methods for treating covid-19 with sepiapterin
TW202329974A (zh) 2021-09-29 2023-08-01 美商 Ptc 治療公司 墨蝶吟之醫藥組合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
WO1997007236A1 (fr) 1995-08-18 1997-02-27 Landry Donald W Detection de composes organiques par regulation de reactions catalysees par des anticorps
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
FR2859996B1 (fr) 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
PT1708690T (pt) * 2003-11-17 2016-09-19 Biomarin Pharm Inc Tratamento de fenilcetonúria com bh4
US7732599B2 (en) 2003-11-17 2010-06-08 Biomarin Pharmaceutical Inc. Process for preparing tetrahydrobiopterin and analogs of tetrahydrobiopterin
CA2678124C (fr) 2003-11-17 2014-10-07 Merck Eprova Ag Formes cristallines de dihydrochlorure de (6r)-l-erythro-tetrahydrobiopterine
EP1845952A2 (fr) 2004-11-17 2007-10-24 Biomarin Pharmaceutical Inc. Formule stable de comprimes de tetrahydrobiopterine
WO2006063215A2 (fr) 2004-12-08 2006-06-15 Biomarin Pharmaceutical Inc. Methodes et compositions de traitement de l'hypertension pulmonaire du nouveau-ne
DE602006005349D1 (de) 2005-04-28 2009-04-09 Shiratori Pharm Verfahren zur herstellung von hydrazon-derivaten
US20080075666A1 (en) 2006-08-25 2008-03-27 Dudley Samuel C Jr Methods and compositions for treating diastolic dysfunction
KR20150080026A (ko) * 2007-04-11 2015-07-08 바이오마린 파머수티컬 인크. 테트라하이드로바이오프테린 투여 방법, 관련 조성물 및 측정 방법
ES2736730T3 (es) 2008-08-12 2020-01-07 Orpha Swiss Gmbh Forma de administración farmacéutica que contiene tetrahidrobiopterina
JP5066756B2 (ja) 2010-04-22 2012-11-07 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
US9884909B2 (en) 2010-12-01 2018-02-06 Alderbio Holdings Llc Anti-NGF compositions and use thereof
US9492451B2 (en) 2011-03-01 2016-11-15 Dipharma S.A. Stable compositions of tetrahydrobiopterin
US9216178B2 (en) * 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
EP2848619B1 (fr) * 2012-05-07 2018-07-11 Shiratori Pharmaceutical Co., Ltd. Procédé de production de sépiaptérine et de tétrahydrolactoylptérine
CN110248948B (zh) 2016-11-29 2023-07-28 Ptc医疗Mp公司 墨蝶呤及其盐的多晶型物
CA3073957A1 (fr) 2017-09-01 2019-03-07 Censa Pharmaceuticals Inc. Composition pharmaceutique comprenant de la sepiapterine et ses utilisations

Also Published As

Publication number Publication date
EP3548487A1 (fr) 2019-10-09
US11130760B2 (en) 2021-09-28
CN110312721A (zh) 2019-10-08
WO2018102314A1 (fr) 2018-06-07
JP2020500931A (ja) 2020-01-16
MX2019006207A (es) 2019-11-18
EP3548487A4 (fr) 2020-04-29
JP7148532B2 (ja) 2022-10-05
US20220081443A1 (en) 2022-03-17
US20200010469A1 (en) 2020-01-09
CA3043499A1 (fr) 2018-06-07

Similar Documents

Publication Publication Date Title
MA46972A (fr) Forme polymorphe de sépiaptérine
DK3180331T3 (da) Polymorfer af selinexor
IL263050B (en) History of Subtirum
DK3558995T3 (da) Polymorfer
DK3191406T3 (da) Fremgangsmåde til fremstilling af aluminiumchloridderivater
DK3558961T3 (da) Polymorfer
IL292245A (en) Polymorphic forms of rad1901–2hcl
IL272697A (en) A polymorphic form of TG02
DK3433183T3 (da) Indvendig beklædning til pallecontainer
IT201600130313A1 (it) Struttura portante di veicolo
DK3373931T3 (da) Heterocykliske forbindelser til behandling af sygdom
DK3302573T3 (da) Sammensætning til behandlingen af hjernelæsioner
DK3180314T3 (da) Fremgangsmåde til fremstilling af syntetiske mellemprodukter til fremstilling af tetrahydroquinolin-derivater
DK3430004T3 (da) Faststofformer af nilotinibsalte
FR3023290B1 (fr) Derives de flavaglines
MA46266A (fr) Formes cristallines
DK3515454T3 (da) Krystallinsk polymorf form af 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl-2-oxo-2lambda5-[1,2]oxaphosphinan
MA48944A (fr) Forme cristalline de n-butyldéoxygalactonojirimycine
ITUA20161550A1 (it) Procedimento per la produzione di RNA
ITUB20169994A1 (it) Nuove forme cristalline di farmaci immunomodulatori
FR3039391B1 (fr) Orthese de contention
IT201700025286A1 (it) Forme cristalline di vinpocetina cloridrato
MA49558A (fr) Dérivativés de 2-oxo-1-imidazolidinyl imidazothiadiazole
UA34108S (uk) Ковдра
UA34109S (uk) Ковдра